BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
25.92
-0.12 (-0.46%)
At close: Nov 12, 2025, 4:00 PM EST
25.92
0.00 (0.00%)
After-hours: Nov 12, 2025, 6:13 PM EST
BioLife Solutions Revenue
BioLife Solutions had revenue of $28.07M in the quarter ending September 30, 2025, with 31.21% growth. This brings the company's revenue in the last twelve months to $100.14M, up 87.53% year-over-year. In the year 2024, BioLife Solutions had annual revenue of $82.25M with 8.44% growth.
Revenue (ttm)
$100.14M
Revenue Growth
+87.53%
P/S Ratio
12.26
Revenue / Employee
$629,836
Employees
159
Market Cap
1.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82.25M | 6.40M | 8.44% |
| Dec 31, 2023 | 75.86M | -384.00K | -0.50% |
| Dec 31, 2022 | 76.24M | -42.92M | -36.02% |
| Dec 31, 2021 | 119.16M | 71.07M | 147.79% |
| Dec 31, 2020 | 48.09M | 20.72M | 75.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BLFS News
- 5 days ago - BioLife Solutions, Inc. (BLFS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - BioLife Solutions Reports Third Quarter 2025 Financial Results - PRNewsWire
- 20 days ago - BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025 - PRNewsWire
- 5 weeks ago - BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary - PRNewsWire
- 6 weeks ago - BioLife: Back To Basics Is Getting Traction (Rating Upgrade) - Seeking Alpha
- 3 months ago - BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLife Solutions Reports Second Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - BioLife Solutions Makes Strategic Investment in Pluristyx - PRNewsWire